D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Broadcom
AVGO
|
+$596M |
| 2 |
Accenture
ACN
|
+$470M |
| 3 |
Intel
INTC
|
+$412M |
| 4 |
Adobe
ADBE
|
+$365M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$258M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$1.5B |
| 2 |
Apple
AAPL
|
+$1.02B |
| 3 |
Microsoft
MSFT
|
+$776M |
| 4 |
Netflix
NFLX
|
+$688M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$542M |
Sector Composition
| 1 | Technology | 26.84% |
| 2 | Consumer Discretionary | 15.19% |
| 3 | Financials | 10.39% |
| 4 | Healthcare | 9.6% |
| 5 | Industrials | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
876
Penske Automotive Group
PAG
$12.2B
| $8.52M | 0.01% |
57,192
+32,022
| +127% | +$4.77M |
|
877
Under Armour
UAA
$2.16B
| $8.5M | 0.01% |
1,273,663
+646,846
| +103% | +$4.31M |
|
878
Aurora
AUR
$10.3B
| $8.47M | 0.01% |
3,058,917
+214,495
| +8% | +$594K |
|
879
Lumen
LUMN
$6.25B
| $8.45M | 0.01% |
7,677,554
-5,921,650
| -44% | -$6.51M |
|
880
James River Group
JRVR
$248M
| $8.43M | 0.01% |
1,090,728
-37,070
| -3% | -$287K |
|
881
Broadridge
BR
$29.8B
| $8.4M | 0.01% |
42,634
-8,143
| -16% | -$1.6M |
|
882
Replimune Group
REPL
$469M
| $8.39M | 0.01% |
931,780
-66,006
| -7% | -$594K |
|
883
Knowles
KN
$1.91B
| $8.38M | 0.01% |
485,542
-44,811
| -8% | -$773K |
|
884
Texas Roadhouse
TXRH
$11.1B
| $8.38M | 0.01% |
48,784
+36,671
| +303% | +$6.3M |
|
885
Ultragenyx Pharmaceutical
RARE
$3.01B
| $8.36M | 0.01% |
+203,442
| New | +$8.36M |
|
886
iShares US Medical Devices ETF
IHI
$4.31B
| $8.36M | 0.01% |
+149,182
| New | +$8.36M |
|
887
ZimVie
ZIMV
$533M
| $8.34M | 0.01% |
457,092
-118,238
| -21% | -$2.16M |
|
888
Qiagen
QGEN
$9.99B
| $8.34M | 0.01% |
197,355
-34,310
| -15% | -$1.45M |
|
889
Nova
NVMI
$8.55B
| $8.34M | 0.01% |
35,543
-55,601
| -61% | -$13M |
|
890
BRF SA
BRFS
$6.09B
| $8.32M | 0.01% |
2,045,138
+693,232
| +51% | +$2.82M |
|
|
WIRE
891
DELISTED
Encore Wire Corp
WIRE
| $8.32M | 0.01% |
28,699
-132,244
| -82% | -$38.3M |
|
892
Edwards Lifesciences
EW
$45.8B
| $8.28M | 0.01% |
89,650
-177,934
| -66% | -$16.4M |
|
893
Pitney Bowes
PBI
$1.97B
| $8.27M | 0.01% |
1,627,634
+68,880
| +4% | +$350K |
|
894
Blackrock
BLK
$176B
| $8.26M | 0.01% |
10,491
+9,691
| +1,211% | +$7.63M |
|
895
Jefferies Financial Group
JEF
$13.9B
| $8.24M | 0.01% |
165,555
+139,882
| +545% | +$6.96M |
|
896
Itron
ITRI
$5.51B
| $8.22M | 0.01% |
83,110
-71,913
| -46% | -$7.12M |
|
897
Nelnet
NNI
$4.51B
| $8.22M | 0.01% |
81,488
-11,596
| -12% | -$1.17M |
|
898
Vir Biotechnology
VIR
$727M
| $8.21M | 0.01% |
922,554
+276,300
| +43% | +$2.46M |
|
899
Addus HomeCare
ADUS
$2.07B
| $8.21M | 0.01% |
70,675
-157
| -0.2% | -$18.2K |
|
900
Manulife Financial
MFC
$54B
| $8.2M | 0.01% |
308,027
+239,627
| +350% | +$6.38M |
|